Drugs / Tibet Rhodiola Capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03163615 | Jun 2017 → Feb 2018 | obstructive sleep apnea syndrome | Shao-Ping Nie | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tibet Rhodiola Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03163615 ↗ |
| Route | Oral | “4 capsules, po, from admission up to 84 days” NCT03163615 ↗ |